Pre-treatment samples were collected from 46 advanced NSCLC patients who had undergone PD-1/PD-L1 blockade therapy, and 27 cases were finally selected for a quantitative image analysis of the tumor immune microenvironment (TIME). Here, CD274 is linked to neoplasm.